Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis

Angiogenesis

Volumn 9, Issue 4, 2006, Pages 183-191

  Fujita, Manabu ^a   Khazenzon, Natalya M ^a   Ljubimov, Alexander V ^a,b   Lee, Bong Seop ^a   Virtanen, Ismo ^c   Holler, Eggehard ^b,d   Black, Keith L ^a,b   Ljubimova, Julia Y ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Arrogene Inc   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Glioma; Laminin 8; Multiple drug targeting; Poly(malic acid); Tumor angiogenesis

Indexed keywords

ANGIOGENESIS INHIBITOR; LAMININ; LAMININ 8; MALIC ACID DERIVATIVE; POLY(MALIC ACID); POLYCEFIN; POLYESTER; POLYMER;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; GLIOMA; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NUDE RAT; RAT; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GLIOMA; HUMANS; LAMININ; MALATES; NEOVASCULARIZATION, PATHOLOGIC; POLYESTERS; POLYMERS; RATS; RATS, NUDE;

EID: 34447554872     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-006-9046-9     Document Type: Article

References (37)

1. Hallmann R, Horn N, Selg M et al (2005) Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85:979-1000 (Pubitemid 40885221)
2. Fujiwara H, Gu J, Sekiguchi K (2004) Rac regulates integrin-mediated endothelial cell adhesion and migration on laminin-8. Exp Cell Res 292:67-77 (Pubitemid 38058264)
3. Ljubimova JY, Lakhter AJ, Loksh A et al (2001) Overexpression of α4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 61:5601-5610 (Pubitemid 32694948)
4. Ljubimova JY, Fugita M, Khazenzon NM et al (2004) Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer 101:604-612 (Pubitemid 38970612)
5. Fujita M, Khazenzon NM, Bose S et al (2005) Overexpression of β1 chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 7:411-421
6. Khazenzon NM, Ljubimov AV, Lakhter AJ et al (2003) Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro. Mol Cancer Ther 2:985-994
7. Torchilin VP, Lukyanov AN (2003) Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 8:259-266 (Pubitemid 36293499)
8. Peterson CM, Shiah J, Sun Y et al (2003) HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer. Adv Exp Med Biol 519:101-123 (Pubitemid 36577703)
9. Maeda H, Fang J, Inutsuka T et al (2003) Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 3:319-328 (Pubitemid 36293960)
10. Satchi-Fainaro R, Puder M, Davies JW et al (2004) Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 10:255-261 (Pubitemid 38667615)
11. Lee BS, Vert M, Holler E (2002) Water-soluble aliphatic polyesters: poly(malic acid)s. In: Doi Y, Steinbüchel A, (ed) Biopolymers, vol 3a. Wiley-VCH, New York, pp 75-103
12. Gasslmaier B, Holler E (1997). Specificity and direction of depolymerization of β-poly(L-malate) catalysed by polymalatase from Physarum polycephalum. Fluorescence labeling at the carboxy-terminus of β-poly(L-malate). Eur J Biochem 250:308-314 (Pubitemid 28012668)
13. Domurado D, Fournié P, Braud C et al (2003) In vivo fates of degradable poly(β-malic acid), and of its precursor, malic acid. J Bioact Compat Pol 18:23-32 (Pubitemid 36648584)
14. Lee BS, Fujita M, Khazenzon NM et al (2006) Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(β-L-malic acid) for drug delivery. Bioconjug Chem 17:317-326
15. Zhang Y, Zhang YF, Bryant J et al (2004) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10:3667-3677 (Pubitemid 38697600)
16. Troncoso P, Ortiz AM, Dominguez J et al (2005) Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury. Transplant Proc 37:4284-4288 (Pubitemid 43016009)
17. Kutryk MJ, Foley DP, van den Brand M et al (2002) Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J Am Coll Cardiol 39:281-287 (Pubitemid 34084634)
18. Lambert DL, Malik N, Shepherd L et al (2001) Localization of c-Myb and induction of apoptosis by antisense oligonucleotide c-Myb after angioplasty of porcine coronary arteries. Arterioscler Thromb Vasc Biol 21:1727-1732 (Pubitemid 34219774)
19. Yoshizumi T, Yonemitsu Y, Ikeda Y et al (2006) Tumor necrosis factor-a antisense transfer remarkably improves hepatic graft viability. Liver Int 26:451-456
20. Countryman RA, Kaban NL, Colombo PJ (2005) Hippocampal c-fos is necessary for long-term memory of a socially transmitted food preference. Neurobiol Learn Mem 84:175-183 (Pubitemid 41457373)
21. Lai SK, Ng TK, Lau WK et al (2004) Selective knockdown of gene expression of N-methyl-D-aspartate receptor one ameliorates parkinsonian motor symptom in 6-hydroxydopamine-lesioned rats. Neurochem Int 45:11-22 (Pubitemid 38479559)
22. Sasaki T, Mann K, Timpl R (2001) Modification of the laminin α4 chain by chondroitin sulfate attachment to its N-terminal domain. FEBS Lett 505:173-178 (Pubitemid 32831052)
23. Rubio L, Burgos JS, Morera C et al (2000) Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients. Pathol Oncol Res 6:210-216
24. Chen B, Pogue BW, Zhou X et al (2005) Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin Cancer Res 11:720-727 (Pubitemid 40116900)
25. Ozawa MG, Yao VJ, Chanthery YH et al (2005) Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma. Cancer 104:2104-2115 (Pubitemid 41579956)
26. de Jong JS, van Diest PJ, Baak JP (1995) Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 73:922-926
27. Gasinska A, Urbanski K, Adamczyk A et al (2002) Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol 41:437-443 (Pubitemid 35222042)
28. Sirica AE, Gainey TW (1997) A new rat bile ductular epithelial cell culture model characterized by the appearance of polarized bile ducts in vitro. Hepatology 26:537-549 (Pubitemid 27392341)
29. Kadoya Y, Yamashina S (1989) Intracellular accumulation of basement membrane components during morphogenesis of rat submandibular gland. J Histochem Cytochem 37:1387-1392 (Pubitemid 19212756)
30. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347-360
31. Jeffes EW, Zhang JG, Hoa N et al (2005) Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma. J Immunol 174:2533-2543 (Pubitemid 40279666)
32. Ruoslahti E (2004) Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans 32:397-402
33. Ningaraj NS, Rao MK, Black KL (2003) Adenosine 5′-triphosphate- sensitive potassium channel-mediated bloodbrain tumor barrier permeability increase in a rat brain tumor model. Cancer Res 63:8899-8911 (Pubitemid 38064070)
34. Fulda S, Wick W, Weller M et al (2002) Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8:808-815
35. Storm PB, Renard VM, Moriarity JL et al (2004) Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma. Cancer Chemother Pharmacol 54:361-367 (Pubitemid 39304431)
36. Kerbel RS, Kamen BA (2004) The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 4:423-436 (Pubitemid 38745528)
37. Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967-974 (Pubitemid 43093963)